Clinical trial NCT01353274: Safety and Efficacy of Daily Use of Micamlo® Combination Tablets AP in Patients With Hypertension
Official title: Survey on Drug Use of Micamlo Combination Tablets AP in Patients With Hypertension
Study type: OBSERVATIONAL
Overall status: COMPLETED
Conditions: Hypertension
Lead sponsor: Boehringer Ingelheim
Sponsor class: INDUSTRY
First posted: 2011-05-13
Enrollment: 1157
Sex: ALL
Standard ages: CHILD
ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Observational model: CASE_ONLY
Time perspective: PROSPECTIVE
Sampling method: NON_PROBABILITY_SAMPLE
Study population: 1200

Brief summary: Investigation of safety and efficacy of daily use of Micamlo Combination Tablets AP in patients with Hypertension


Eligibility criteria: Inclusion criteria:

- Male and Female patients with hypertension who did not receive of MICAMLO Combination Tablets AP before the start of the study

Exclusion criteria:

* Patients with a history of hypersensitivity to any ingredient of Micamlo Combination Tablets AP and dihydropyridine derivatives
* Pregnant woman or possibly pregnant woman
* Patients with extremely poor bile secretion or patients with serious hepatic disorder

Primary outcomes:
measure: Incidence of Drug-related Adverse Events
timeFrame: 12 months
Secondary outcomes:
measure: Change From Baseline in Systolic Blood Pressure (SBP)
timeFrame: after 1, 2, 3, 6, 12 months
measure: Change From Baseline in Diastolic Blood Pressure (DBP)
timeFrame: after 1, 2, 3, 6, 12 months
measure: Proportion of Patients Who Achieved the Target BP
timeFrame: after 1, 2, 3, 6, 12 months
measure: Proportion of Patients Who Normalised Their BP
timeFrame: after 1, 2, 3, 6, 12 months
Other outcomes:
Locations:
city: Akaiwa
country: Japan
facility: Boehringer Ingelheim Investigational Site 199
city: Akishima
country: Japan
facility: Boehringer Ingelheim Investigational Site 83
city: Akita
country: Japan
facility: Boehringer Ingelheim Investigational Site 25
city: Amagasaki
country: Japan
facility: Boehringer Ingelheim Investigational Site 188
city: Anamizu-machi
country: Japan
facility: Boehringer Ingelheim Investigational Site 116
city: Anan
country: Japan
facility: Boehringer Ingelheim Investigational Site 212
city: Anjo
country: Japan
facility: Boehringer Ingelheim Investigational Site 145
city: Aomori
country: Japan
facility: Boehringer Ingelheim Investigational Site 11
city: Aomori
country: Japan
facility: Boehringer Ingelheim Investigational Site 12
city: Arita
country: Japan
facility: Boehringer Ingelheim Investigational Site 192
city: Asahikawa
country: Japan
facility: Boehringer Ingelheim Investigational Site 7
city: Atsugi
country: Japan
facility: Boehringer Ingelheim Investigational Site 104
city: Chiba
country: Japan
facility: Boehringer Ingelheim Investigational Site 57
city: Chiba
country: Japan
facility: Boehringer Ingelheim Investigational Site 58
city: Chikuzen-machi
country: Japan
facility: Boehringer Ingelheim Investigational Site 232
city: Chita
country: Japan
facility: Boehringer Ingelheim Investigational Site 143
city: Daisen
country: Japan
facility: Boehringer Ingelheim Investigational Site 23
city: Daisen
country: Japan
facility: Boehringer Ingelheim Investigational Site 24
city: Date
country: Japan
facility: Boehringer Ingelheim Investigational Site 10
city: Fuchu
country: Japan
facility: Boehringer Ingelheim Investigational Site 90
city: Fujimino
country: Japan
facility: Boehringer Ingelheim Investigational Site 52
city: Fujinomiya
country: Japan
facility: Boehringer Ingelheim Investigational Site 129
city: Fujisawa
country: Japan
facility: Boehringer Ingelheim Investigational Site 103
city: Fukuchiyama
country: Japan
facility: Boehringer Ingelheim Investigational Site 158
city: Fukuoka
country: Japan
facility: Boehringer Ingelheim Investigational Site 224
city: Fukuoka
country: Japan
facility: Boehringer Ingelheim Investigational Site 225
city: Fukushima
country: Japan
facility: Boehringer Ingelheim Investigational Site 29
city: Hachinohe
country: Japan
facility: Boehringer Ingelheim Investigational Site 13
city: Hamamatsu
country: Japan
facility: Boehringer Ingelheim Investigational Site 130
city: Hamamatsu
country: Japan
facility: Boehringer Ingelheim Investigational Site 131
city: Handa
country: Japan
facility: Boehringer Ingelheim Investigational Site 219
city: Hannan
country: Japan
facility: Boehringer Ingelheim Investigational Site 171
city: Hatsukaichi
country: Japan
facility: Boehringer Ingelheim Investigational Site 204
city: Higashihiroshima
country: Japan
facility: Boehringer Ingelheim Investigational Site 208
city: Higashikagura-cho
country: Japan
facility: Boehringer Ingelheim Investigational Site 5
city: Higashimurayama
country: Japan
facility: Boehringer Ingelheim Investigational Site 66
city: Hikone
country: Japan
facility: Boehringer Ingelheim Investigational Site 151
city: Himeji
country: Japan
facility: Boehringer Ingelheim Investigational Site 179
city: Himeji
country: Japan
facility: Boehringer Ingelheim Investigational Site 180
city: Himeji
country: Japan
facility: Boehringer Ingelheim Investigational Site 181
city: Hirakata
country: Japan
facility: Boehringer Ingelheim Investigational Site 169
city: Hirakata
country: Japan
facility: Boehringer Ingelheim Investigational Site 170
city: Hiroshima
country: Japan
facility: Boehringer Ingelheim Investigational Site 201
city: Hiroshima
country: Japan
facility: Boehringer Ingelheim Investigational Site 202
city: Hiroshima
country: Japan
facility: Boehringer Ingelheim Investigational Site 203
city: Hitachinaka
country: Japan
facility: Boehringer Ingelheim Investigational Site 38
city: Hitachiota
country: Japan
facility: Boehringer Ingelheim Investigational Site 37
city: Ichikawa
country: Japan
facility: Boehringer Ingelheim Investigational Site 62
city: Ichinoseki
country: Japan
facility: Boehringer Ingelheim Investigational Site 17
city: Iizuka
country: Japan
facility: Boehringer Ingelheim Investigational Site 223
city: Ikeda
country: Japan
facility: Boehringer Ingelheim Investigational Site 175
city: IKisarazu
country: Japan
facility: Boehringer Ingelheim Investigational Site 63
city: Iki
country: Japan
facility: Boehringer Ingelheim Investigational Site 238
city: Ikoma
country: Japan
facility: Boehringer Ingelheim Investigational Site 191
city: Imizu
country: Japan
facility: Boehringer Ingelheim Investigational Site 111
city: Itami
country: Japan
facility: Boehringer Ingelheim Investigational Site 189
city: Itoman
country: Japan
facility: Boehringer Ingelheim Investigational Site 253
city: Itoshima
country: Japan
facility: Boehringer Ingelheim Investigational Site 233
city: Izumi
country: Japan
facility: Boehringer Ingelheim Investigational Site 252
city: Kagamihara
country: Japan
facility: Boehringer Ingelheim Investigational Site 125
city: Kagoshima
country: Japan
facility: Boehringer Ingelheim Investigational Site 249
city: Kagoshima
country: Japan
facility: Boehringer Ingelheim Investigational Site 250
city: Kama
country: Japan
facility: Boehringer Ingelheim Investigational Site 229
city: Kameoka
country: Japan
facility: Boehringer Ingelheim Investigational Site 152
city: Kamiamakusa
country: Japan
facility: Boehringer Ingelheim Investigational Site 241
city: Kamiamakusa
country: Japan
facility: Boehringer Ingelheim Investigational Site 242
city: Kamimachi
country: Japan
facility: Boehringer Ingelheim Investigational Site 22
city: Kanazawa
country: Japan
facility: Boehringer Ingelheim Investigational Site 113
city: Kanazawa
country: Japan
facility: Boehringer Ingelheim Investigational Site 114
city: Kanzaki
country: Japan
facility: Boehringer Ingelheim Investigational Site 237
city: Kariya
country: Japan
facility: Boehringer Ingelheim Investigational Site 144
city: Kasama
country: Japan
facility: Boehringer Ingelheim Investigational Site 33
city: Kasama
country: Japan
facility: Boehringer Ingelheim Investigational Site 34
city: Kasugai
country: Japan
facility: Boehringer Ingelheim Investigational Site 137
city: Kasugai
country: Japan
facility: Boehringer Ingelheim Investigational Site 138
city: Kasukabe
country: Japan
facility: Boehringer Ingelheim Investigational Site 48
city: Kasukabe
country: Japan
facility: Boehringer Ingelheim Investigational Site 49
city: Kato
country: Japan
facility: Boehringer Ingelheim Investigational Site 177
city: Kato
country: Japan
facility: Boehringer Ingelheim Investigational Site 178
city: Katsuyama
country: Japan
facility: Boehringer Ingelheim Investigational Site 117
city: Kawachinagano
country: Japan
facility: Boehringer Ingelheim Investigational Site 121
city: Kawaguchi
country: Japan
facility: Boehringer Ingelheim Investigational Site 51
city: Kawasaki
country: Japan
facility: Boehringer Ingelheim Investigational Site 100
city: Kawasaki
country: Japan
facility: Boehringer Ingelheim Investigational Site 101
city: Kiryu
country: Japan
facility: Boehringer Ingelheim Investigational Site 43
city: Kita-ku
country: Japan
facility: Boehringer Ingelheim Investigational Site 176
city: Kitakami
country: Japan
facility: Boehringer Ingelheim Investigational Site 15
city: Kitakyushu
country: Japan
facility: Boehringer Ingelheim Investigational Site 226
city: Kitakyushu
country: Japan
facility: Boehringer Ingelheim Investigational Site 227
city: Kitami
country: Japan
facility: Boehringer Ingelheim Investigational Site 4
city: Kobe
country: Japan
facility: Boehringer Ingelheim Investigational Site 183
city: Kobe
country: Japan
facility: Boehringer Ingelheim Investigational Site 184
city: Kobe
country: Japan
facility: Boehringer Ingelheim Investigational Site 185
city: Kobe
country: Japan
facility: Boehringer Ingelheim Investigational Site 186
city: Kobe
country: Japan
facility: Boehringer Ingelheim Investigational Site 187
city: Kochi
country: Japan
facility: Boehringer Ingelheim Investigational Site 220
city: Koriyama
country: Japan
facility: Boehringer Ingelheim Investigational Site 30
city: Koshigaya
country: Japan
facility: Boehringer Ingelheim Investigational Site 56
city: Kotoura-cho
country: Japan
facility: Boehringer Ingelheim Investigational Site 193
city: Kotouracho
country: Japan
facility: Boehringer Ingelheim Investigational Site 240
city: Kumagaya
country: Japan
facility: Boehringer Ingelheim Investigational Site 53
city: Kumamoto
country: Japan
facility: Boehringer Ingelheim Investigational Site 243
city: Kurashiki
country: Japan
facility: Boehringer Ingelheim Investigational Site 196
city: Kure
country: Japan
facility: Boehringer Ingelheim Investigational Site 205
city: Kure
country: Japan
facility: Boehringer Ingelheim Investigational Site 206
city: Kurume
country: Japan
facility: Boehringer Ingelheim Investigational Site 230
city: Kurume
country: Japan
facility: Boehringer Ingelheim Investigational Site 231
city: Kusatsu
country: Japan
facility: Boehringer Ingelheim Investigational Site 149
city: Kushiro
country: Japan
facility: Boehringer Ingelheim Investigational Site 9
city: Kyoto
country: Japan
facility: Boehringer Ingelheim Investigational Site 153
city: Kyoto
country: Japan
facility: Boehringer Ingelheim Investigational Site 154
city: Kyoto
country: Japan
facility: Boehringer Ingelheim Investigational Site 155
city: Kyoto
country: Japan
facility: Boehringer Ingelheim Investigational Site 156
city: Kyoto
country: Japan
facility: Boehringer Ingelheim Investigational Site 157
city: Matsuda-machi
country: Japan
facility: Boehringer Ingelheim Investigational Site 99
city: Matsudo
country: Japan
facility: Boehringer Ingelheim Investigational Site 64
city: Matsudo
country: Japan
facility: Boehringer Ingelheim Investigational Site 65
city: Matsue
country: Japan
facility: Boehringer Ingelheim Investigational Site 195
city: Matsumoto
country: Japan
facility: Boehringer Ingelheim Investigational Site 119
city: Matsumoto
country: Japan
facility: Boehringer Ingelheim Investigational Site 120
city: Matsuura
country: Japan
facility: Boehringer Ingelheim Investigational Site 234
city: Matsuyama
country: Japan
facility: Boehringer Ingelheim Investigational Site 216
city: Matsuyama
country: Japan
facility: Boehringer Ingelheim Investigational Site 217
city: Matsuzaka
country: Japan
facility: Boehringer Ingelheim Investigational Site 148
city: Mihara
country: Japan
facility: Boehringer Ingelheim Investigational Site 207
city: Minamiminowa-mura
country: Japan
facility: Boehringer Ingelheim Investigational Site 122
city: Miyazaki
country: Japan
facility: Boehringer Ingelheim Investigational Site 248
city: Mizunami
country: Japan
facility: Boehringer Ingelheim Investigational Site 126
city: Mobara
country: Japan
facility: Boehringer Ingelheim Investigational Site 60
city: Mobara
country: Japan
facility: Boehringer Ingelheim Investigational Site 61
city: Morioka
country: Japan
facility: Boehringer Ingelheim Investigational Site 16
city: Murayama
country: Japan
facility: Boehringer Ingelheim Investigational Site 27
city: Nagaoka
country: Japan
facility: Boehringer Ingelheim Investigational Site 105
city: Nagaoka
country: Japan
facility: Boehringer Ingelheim Investigational Site 106
city: Nagasaki
country: Japan
facility: Boehringer Ingelheim Investigational Site 235
city: Nagoya
country: Japan
facility: Boehringer Ingelheim Investigational Site 139
city: Nagoya
country: Japan
facility: Boehringer Ingelheim Investigational Site 140
city: Nagoya
country: Japan
facility: Boehringer Ingelheim Investigational Site 141
city: Nagoya
country: Japan
facility: Boehringer Ingelheim Investigational Site 142
city: Nago
country: Japan
facility: Boehringer Ingelheim Investigational Site 254
city: Nakagawa-machi
country: Japan
facility: Boehringer Ingelheim Investigational Site 228
city: Nakagawa-machi
country: Japan
facility: Boehringer Ingelheim Investigational Site 39
city: Nakatsugawa
country: Japan
facility: Boehringer Ingelheim Investigational Site 127
city: Nakatsu
country: Japan
facility: Boehringer Ingelheim Investigational Site 245
city: Narita
country: Japan
facility: Boehringer Ingelheim Investigational Site 59
city: Natori
country: Japan
facility: Boehringer Ingelheim Investigational Site 18
city: Nayoro
country: Japan
facility: Boehringer Ingelheim Investigational Site 8
city: Nichinan
country: Japan
facility: Boehringer Ingelheim Investigational Site 246
city: Nihonmatsu
country: Japan
facility: Boehringer Ingelheim Investigational Site 31
city: Niigata
country: Japan
facility: Boehringer Ingelheim Investigational Site 107
city: Niimi
country: Japan
facility: Boehringer Ingelheim Investigational Site 200
city: Nikki-cho
country: Japan
facility: Boehringer Ingelheim Investigational Site 6
city: Nishiizu-cho
country: Japan
facility: Boehringer Ingelheim Investigational Site 128
city: Nishinomiya
country: Japan
facility: Boehringer Ingelheim Investigational Site 182
city: Nomi
country: Japan
facility: Boehringer Ingelheim Investigational Site 112
city: Numazu
country: Japan
facility: Boehringer Ingelheim Investigational Site 134
city: Odate
country: Japan
facility: Boehringer Ingelheim Investigational Site 26
city: Ogaki
country: Japan
facility: Boehringer Ingelheim Investigational Site 124
city: Oita
country: Japan
facility: Boehringer Ingelheim Investigational Site 244
city: Okayama
country: Japan
facility: Boehringer Ingelheim Investigational Site 197
city: Okayama
country: Japan
facility: Boehringer Ingelheim Investigational Site 198
city: Omamachi
country: Japan
facility: Boehringer Ingelheim Investigational Site 14
city: Omura
country: Japan
facility: Boehringer Ingelheim Investigational Site 239
city: Osaka
country: Japan
facility: Boehringer Ingelheim Investigational Site 159
city: Osaka
country: Japan
facility: Boehringer Ingelheim Investigational Site 160
city: Osaka
country: Japan
facility: Boehringer Ingelheim Investigational Site 161
city: Osaka
country: Japan
facility: Boehringer Ingelheim Investigational Site 162
city: Osaka
country: Japan
facility: Boehringer Ingelheim Investigational Site 163
city: Osaka
country: Japan
facility: Boehringer Ingelheim Investigational Site 164
city: Osaka
country: Japan
facility: Boehringer Ingelheim Investigational Site 165
city: Osaka
country: Japan
facility: Boehringer Ingelheim Investigational Site 166
city: Osaka
country: Japan
facility: Boehringer Ingelheim Investigational Site 167
city: Osaka
country: Japan
facility: Boehringer Ingelheim Investigational Site 168
city: Oyama
country: Japan
facility: Boehringer Ingelheim Investigational Site 40
city: Ryugasaki
country: Japan
facility: Boehringer Ingelheim Investigational Site 35
city: Sagamihara
country: Japan
facility: Boehringer Ingelheim Investigational Site 102
city: Saga
country: Japan
facility: Boehringer Ingelheim Investigational Site 236
city: Saitama
country: Japan
facility: Boehringer Ingelheim Investigational Site 46
city: Saitama
country: Japan
facility: Boehringer Ingelheim Investigational Site 47
city: Sakaide
country: Japan
facility: Boehringer Ingelheim Investigational Site 215
city: Sakai
country: Japan
facility: Boehringer Ingelheim Investigational Site 172
city: Sakai
country: Japan
facility: Boehringer Ingelheim Investigational Site 173
city: Sakaki-machi
country: Japan
facility: Boehringer Ingelheim Investigational Site 118
city: Sanjyo
country: Japan
facility: Boehringer Ingelheim Investigational Site 108
city: Sano
country: Japan
facility: Boehringer Ingelheim Investigational Site 41
city: Sapporo
country: Japan
facility: Boehringer Ingelheim Investigational Site 1
city: Sapporo
country: Japan
facility: Boehringer Ingelheim Investigational Site 2
city: Sapporo
country: Japan
facility: Boehringer Ingelheim Investigational Site 3
city: Sayama
country: Japan
facility: Boehringer Ingelheim Investigational Site 55
city: Sendai
country: Japan
facility: Boehringer Ingelheim Investigational Site 21
city: Shika-machi
country: Japan
facility: Boehringer Ingelheim Investigational Site 115
city: Shimonoseki
country: Japan
facility: Boehringer Ingelheim Investigational Site 210
city: Shiogama
country: Japan
facility: Boehringer Ingelheim Investigational Site 19
city: Shirakawa
country: Japan
facility: Boehringer Ingelheim Investigational Site 32
city: Shizuoka
country: Japan
facility: Boehringer Ingelheim Investigational Site 132
city: Shizuoka
country: Japan
facility: Boehringer Ingelheim Investigational Site 133
city: Soka
country: Japan
facility: Boehringer Ingelheim Investigational Site 50
city: Suita
country: Japan
facility: Boehringer Ingelheim Investigational Site 174
city: Suzuka
country: Japan
facility: Boehringer Ingelheim Investigational Site 147
city: Tachikawa
country: Japan
facility: Boehringer Ingelheim Investigational Site 69
city: Tachikawa
country: Japan
facility: Boehringer Ingelheim Investigational Site 70
city: Tachikawa
country: Japan
facility: Boehringer Ingelheim Investigational Site 71
city: Tagajyo
country: Japan
facility: Boehringer Ingelheim Investigational Site 20
city: Takasaki
country: Japan
facility: Boehringer Ingelheim Investigational Site 44
city: Takasaki
country: Japan
facility: Boehringer Ingelheim Investigational Site 45
city: Takashima
country: Japan
facility: Boehringer Ingelheim Investigational Site 150
city: Tama
country: Japan
facility: Boehringer Ingelheim Investigational Site 84
city: Tendo
country: Japan
facility: Boehringer Ingelheim Investigational Site 28
city: Tokamachi
country: Japan
facility: Boehringer Ingelheim Investigational Site 109
city: Tokushima
country: Japan
facility: Boehringer Ingelheim Investigational Site 213
city: Tokyo Adachi-ku
country: Japan
facility: Boehringer Ingelheim Investigational Site 72
city: Tokyo Adachi-ku
country: Japan
facility: Boehringer Ingelheim Investigational Site 73
city: Tokyo Bunkyo-ku
country: Japan
facility: Boehringer Ingelheim Investigational Site 74
city: Tokyo Bunkyo-ku
country: Japan
facility: Boehringer Ingelheim Investigational Site 75
city: Tokyo Chuo-ku
country: Japan
facility: Boehringer Ingelheim Investigational Site 79
city: Tokyo Edofawa-ku
country: Japan
facility: Boehringer Ingelheim Investigational Site 77
city: Tokyo Itabashi-ku
country: Japan
facility: Boehringer Ingelheim Investigational Site 76
city: Tokyo Katsushika-ku
country: Japan
facility: Boehringer Ingelheim Investigational Site 89
city: Tokyo Meguro-ku
country: Japan
facility: Boehringer Ingelheim Investigational Site 85
city: Tokyo Meguro-ku
country: Japan
facility: Boehringer Ingelheim Investigational Site 86
city: Tokyo Nerima-ku
country: Japan
facility: Boehringer Ingelheim Investigational Site 81
city: Tokyo Nerima-ku
country: Japan
facility: Boehringer Ingelheim Investigational Site 82
city: Tokyo Ota-ku
country: Japan
facility: Boehringer Ingelheim Investigational Site 87
city: Tokyo Shinjyuku-ku
country: Japan
facility: Boehringer Ingelheim Investigational Site 67
city: Tokyo Shinjyuku-ku
country: Japan
facility: Boehringer Ingelheim Investigational Site 68
city: Tokyo Sumida-ku
country: Japan
facility: Boehringer Ingelheim Investigational Site 78
city: Tokyo Sumida-ku
country: Japan
facility: Boehringer Ingelheim Investigational Site 88
city: Tokyo Toshima-ku
country: Japan
facility: Boehringer Ingelheim Investigational Site 80
city: Tonosho-cho
country: Japan
facility: Boehringer Ingelheim Investigational Site 214
city: Tosashimizu
country: Japan
facility: Boehringer Ingelheim Investigational Site 221
city: Toyama
country: Japan
facility: Boehringer Ingelheim Investigational Site 110
city: Toyohashi
country: Japan
facility: Boehringer Ingelheim Investigational Site 135
city: Toyohashi
country: Japan
facility: Boehringer Ingelheim Investigational Site 136
city: Tsuchiura
country: Japan
facility: Boehringer Ingelheim Investigational Site 36
city: Tsunocho
country: Japan
facility: Boehringer Ingelheim Investigational Site 247
city: Tsu
country: Japan
facility: Boehringer Ingelheim Investigational Site 146
city: Ube
country: Japan
facility: Boehringer Ingelheim Investigational Site 209
city: Ueda
country: Japan
facility: Boehringer Ingelheim Investigational Site 123
city: Utsunomiya
country: Japan
facility: Boehringer Ingelheim Investigational Site 42
city: Uwajima
country: Japan
facility: Boehringer Ingelheim Investigational Site 218
city: Wadomari-cho
country: Japan
facility: Boehringer Ingelheim Investigational Site 251
city: Yamaguchi
country: Japan
facility: Boehringer Ingelheim Investigational Site 211
city: Yamatokooriyama
country: Japan
facility: Boehringer Ingelheim Investigational Site 190
city: Yame
country: Japan
facility: Boehringer Ingelheim Investigational Site 222
city: Yokohama
country: Japan
facility: Boehringer Ingelheim Investigational Site 93
city: Yokohama
country: Japan
facility: Boehringer Ingelheim Investigational Site 94
city: Yokohama
country: Japan
facility: Boehringer Ingelheim Investigational Site 95
city: Yokohama
country: Japan
facility: Boehringer Ingelheim Investigational Site 96
city: Yokohama
country: Japan
facility: Boehringer Ingelheim Investigational Site 97
city: Yokosuka
country: Japan
facility: Boehringer Ingelheim Investigational Site 91
city: Yokosuka
country: Japan
facility: Boehringer Ingelheim Investigational Site 92
city: Yokoze-machi
country: Japan
facility: Boehringer Ingelheim Investigational Site 54
city: Yonago
country: Japan
facility: Boehringer Ingelheim Investigational Site 194
city: Zama
country: Japan
facility: Boehringer Ingelheim Investigational Site 98
Study officials:
affiliation: Boehringer Ingelheim
name: Boehringer Ingelheim
role: STUDY_CHAIR
References: